Search Results - "Ackl, N"
-
1
A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline
Published in Journal of the neurological sciences (15-01-2011)“…Abstract Hemiplegic migraine (HM) is a rare and severe subtype of migraine with aura, characterized by some degree of hemiparesis and other aura symptoms…”
Get full text
Journal Article -
2
A Pair of Siblings with a rare R5H-Mutation in Exon 1 of the MAPT-Gene
Published in Fortschritte der Neurologie-Psychiatrie (01-07-2015)“…We report on a female patient presenting with primary progressive aphasia (PPA) and her brother presenting with psychosis. Both siblings had an R5H-mutation in…”
Get more information
Journal Article -
3
Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated
Published in Journal of psychiatric research (01-05-2000)“…Clinical and preclinical data suggest that unrestrained secretion of corticoctropin-releasing hormone (CRH) in the CNS produces several signs and symptoms of…”
Get full text
Journal Article -
4
Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease
Published in Neuroscience letters (12-08-2005)“…Mild cognitive impairment (MCI) defines a group of otherwise healthy elderly subjects with a markedly elevated risk of developing Alzheimer's disease (AD). In…”
Get full text
Journal Article -
5
Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects
Published in Journal of psychiatric research (01-11-2003)“…A dysregulation of the hypothalamus-pituitary-adrenocortical (HPA) system has been hypothesized to account for a myriad of cardinal symptoms of affective…”
Get full text
Journal Article -
6
Clinical and neurobiological effects of tianeptine and paroxetine in major depression
Published in Journal of clinical psychopharmacology (01-04-2003)“…Selective serotonin reuptake inhibitors (SSRIs) are widely used as effective pharmacological agents to treat depressive disorders. In contrast to the SSRIs,…”
Get full text
Journal Article -
7
Amyloid positron-emission-tomography with [ 18 F-florbetaben in the diagnostic workup of dementia patients
Published in Nervenarzt (01-02-2017)“…To this day the definite diagnosis of Alzheimer's disease still relies on post-mortem histopathological detection of neurofibrillary tangles and beta-amyloid…”
Get full text
Journal Article -
8
Amyloid-Positronenemissionstomographie mit [18 F]-Florbetaben in der Demenzdiagnostik
Published in Nervenarzt (01-02-2017)“…Zusammenfassung Hintergrund Eine gesicherte Diagnose der Alzheimer-Krankheit beruht auf dem histologischen Nachweis von Neurofibrillen und…”
Get full text
Journal Article -
9
Toward a Reliable Distinction Between Patients with Mild Cognitive Impairment and Alzheimer-Type Dementia Versus Major Depression
Published in Biological psychiatry (1969) (01-05-2006)“…Cerebrospinal fluid (CSF) levels of soluble amyloid precursor protein (sAPP) and its α-secreted form (α-sAPP) were investigated as a means to distinguish…”
Get full text
Journal Article -
10
Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression
Published in Journal of psychiatric research (01-03-2005)“…Weight gain during treatment with psychotropic drugs is frequently observed and is assumed to be responsible for non-compliance and for an elevated risk to…”
Get full text
Journal Article -
11
Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia
Published in Collegium antropologicum (01-01-2008)“…Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common causes of dementia in old people. They remain difficult to differentiate in…”
Get more information
Journal Article -
12
CRH, HPA system hyperactivity and depression
Published in European neuropsychopharmacology (01-09-2000)Get full text
Journal Article